SALVIA, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 25.245
EU - Europa 25.015
AS - Asia 17.873
SA - Sud America 2.553
AF - Africa 613
OC - Oceania 59
Continente sconosciuto - Info sul continente non disponibili 12
AN - Antartide 1
Totale 71.371
Nazione #
US - Stati Uniti d'America 24.678
RU - Federazione Russa 10.118
SG - Singapore 7.317
CN - Cina 5.142
GB - Regno Unito 4.694
IT - Italia 2.798
BR - Brasile 2.059
HK - Hong Kong 1.593
VN - Vietnam 1.573
DE - Germania 1.491
SE - Svezia 1.292
FR - Francia 1.201
IE - Irlanda 1.112
FI - Finlandia 795
KR - Corea 544
IN - India 316
CA - Canada 307
NL - Olanda 306
UA - Ucraina 268
JP - Giappone 263
AR - Argentina 190
ES - Italia 179
MX - Messico 178
TR - Turchia 170
BD - Bangladesh 152
NG - Nigeria 134
PL - Polonia 131
ID - Indonesia 128
AT - Austria 122
ZA - Sudafrica 122
IQ - Iraq 113
BE - Belgio 88
CZ - Repubblica Ceca 80
TG - Togo 78
PK - Pakistan 77
BJ - Benin 62
EC - Ecuador 59
MA - Marocco 56
LT - Lituania 55
UZ - Uzbekistan 55
VE - Venezuela 54
CO - Colombia 52
AU - Australia 48
CL - Cile 41
PH - Filippine 41
SA - Arabia Saudita 41
AE - Emirati Arabi Uniti 39
JO - Giordania 39
PY - Paraguay 38
EG - Egitto 35
CH - Svizzera 33
KE - Kenya 31
NP - Nepal 30
TN - Tunisia 30
IL - Israele 29
IR - Iran 27
AZ - Azerbaigian 26
PE - Perù 25
RO - Romania 25
KG - Kirghizistan 21
AL - Albania 20
PT - Portogallo 20
LV - Lettonia 19
DZ - Algeria 18
SI - Slovenia 18
KZ - Kazakistan 17
MY - Malesia 17
GR - Grecia 16
UY - Uruguay 16
HR - Croazia 15
HU - Ungheria 15
RS - Serbia 15
BO - Bolivia 14
JM - Giamaica 13
LB - Libano 13
OM - Oman 13
BG - Bulgaria 12
CR - Costa Rica 12
NO - Norvegia 12
DK - Danimarca 11
PA - Panama 11
DO - Repubblica Dominicana 9
LU - Lussemburgo 9
SK - Slovacchia (Repubblica Slovacca) 9
BY - Bielorussia 8
ET - Etiopia 8
EU - Europa 8
PS - Palestinian Territory 8
AM - Armenia 7
BA - Bosnia-Erzegovina 7
EE - Estonia 7
SY - Repubblica araba siriana 7
TH - Thailandia 7
TT - Trinidad e Tobago 7
BH - Bahrain 6
GA - Gabon 6
KW - Kuwait 6
NZ - Nuova Zelanda 6
QA - Qatar 6
BB - Barbados 5
Totale 71.254
Città #
Singapore 3.943
Southend 3.902
Moscow 3.675
Dallas 3.141
Ashburn 3.022
Chandler 2.453
San Jose 2.437
Hong Kong 1.569
Jacksonville 1.382
Verona 1.236
Dublin 1.080
Woodbridge 1.070
The Dalles 920
Beijing 856
Ann Arbor 646
Houston 603
New York 591
Ho Chi Minh City 529
Los Angeles 485
Munich 456
Lawrence 374
Princeton 374
Wilmington 352
Jinan 350
Hanoi 345
Nanjing 293
Helsinki 255
Shenyang 255
Tokyo 228
São Paulo 224
Santa Clara 221
Buffalo 209
Council Bluffs 197
Redondo Beach 189
Sindelfingen 185
Orem 177
Redmond 177
Tianjin 175
Hebei 170
Milan 165
Columbus 158
London 158
Turku 143
Hangzhou 129
Haikou 127
Seattle 123
Montreal 122
Abuja 121
Zhengzhou 118
Warsaw 113
Frankfurt am Main 110
Ningbo 108
Amsterdam 107
Stockholm 103
Changsha 100
Chennai 100
Denver 100
Guangzhou 97
Taiyuan 95
Nanchang 89
Toronto 88
Brooklyn 85
Taizhou 85
Brussels 84
Atlanta 82
San Francisco 81
Johannesburg 80
Rio de Janeiro 80
Lancaster 79
Boardman 78
Lomé 78
Da Nang 77
Nuremberg 75
Rome 75
Jiaxing 74
Poplar 71
Chicago 70
Fairfield 70
Seoul 70
Falkenstein 68
Lappeenranta 67
Phoenix 67
Haiphong 66
Jakarta 66
Vienna 65
Bologna 64
Mexico City 63
Belo Horizonte 62
Cotonou 62
Washington 59
Redwood City 52
Brno 51
Manchester 50
Mumbai 50
Paris 49
Fuzhou 47
Tashkent 47
Falls Church 45
Norwalk 45
Kent 43
Totale 43.902
Nome #
Supplemental parenteral nutrition within an enhanced recovery program for open pancreatoduodenectomy for cancer: a pragmatic, multicenter, randomized controlled trial 392
Assessment of Psychological Burden in Individuals with Hereditary Risk of Pancreatic Cancer Under Surveillance: Evaluation of Distress 3 Years After Enrollment 328
Resezione intermedia e pancreasectomia distale per neoplasie benigne del pancreas: confronto per complicanze postoperatorie e costi 282
Genomic characterization of hepatoid tumors: context matters 260
Branch duct IPMTs: value of cross-sectional imaging in the assessment of biological behavior and follow-up. 255
(Intraductal papillary mucinous tumors) Clinical manifestations and therapeutic management. 253
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 251
Genomic analyses identify molecular subtypes of pancreatic cancer 251
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial 246
Alcohol and smoking as risk factors in chronic pancreatitits and pancreatic cancer 245
Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations 245
"Paraduodenal" pancreatitis: results of surgery on 58 consecutives patients from a single institution. 241
A Single Institution's 27-Year Surgical Experience with Pancreatic Neuroendocrine Tumors: Time Trends, Comparison of Current Staging Systems and Outcome Analysis 238
Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity? Results from a Single-Center Surgical Series 237
Association between macroscopically visible tissue samples and diagnostic accuracy of EUS-guided through-the-needle microforceps biopsy sampling of pancreatic cystic lesions 235
The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution. 233
[Closed surgical treatment in acute severe pancreatitis] 232
Central pancreatectomy for benign or low-grade malignant pancreatic lesions - A single-center retrospective analysis of 116 cases 232
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 232
Gα15 in early onset of pancreatic ductal adenocarcinoma 232
Differences between main-duct and branch-duct intraductal papillary mucinous neoplasms of the pancreas 230
Acoustic radiation force impulse (ARFI) ultrasound imaging of pancreatic cystic lesions 226
Amylase value in drains after pancreatic resection as predictive factor of postoperative pancreatic fistula: results of a prospective study in 137 patients. 224
Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas 223
"Trivial" Cysts Redefine the Risk of Cancer in Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Potential Target for Follow-Up Discontinuation? 222
A case of intraductal papillary mucinous tumour following recurrent attacks of pancreatitis lasting 26 years 221
Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma 221
A root-cause analysis of mortality following major pancreatectomy 221
Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center 217
A prospective non-randomised single-center study comparing laparoscopic and robotic distal pancreatectomy 217
A multimodality test to guide the management of patients with a pancreatic cyst 217
Observational study of the incidence of pancreatic and extrapancreatic malignancies during surveillance of patients with branch-duct intraductal papillary mucinous neoplasm 216
A case of intraductal papillary mucinous tumour following recurrent attacks of pancreatitis lasting 26 years. 215
"Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms 215
Is there a role for near-infrared technology in laparoscopic resection of pancreatic neuroendocrine tumors? Results of the COLPAN "colour-and-resect the pancreas" study 214
Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors 214
Antibiotic Prophylaxis with Piperacillin-Tazobactam Reduces Post-Operative Infectious Complication after Pancreatic Surgery: An Interventional, Non-Randomized Study 213
Pancreatic Enucleation Patients Share the Same Quality of Life as the General Population at Long-Term Follow-Up: A Propensity-Score Matched Analysis 211
Expression of inducible nitric oxide synthase and cyclooxygenase-2 in human pancreas 210
Triple approach strategy for patients with locally advanced pancreatic carcinoma 210
Reinforced stapler versus ultrasonic dissector for pancreatic transection and stump closure for distal pancreatectomy: A propensity matched analysis 208
Radiofrequency ablation for locally advanced pancreatic cancer: SMAD4 analysis segregates a responsive subgroup of patients 208
Combined modality treatment for patients with locally advanced pancreatic adenocarcinoma 206
Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate? Results of a prospective protocol on the management of 109 consecutive patients. 205
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts 205
An Overview of Artificial Intelligence Applications in Liver and Pancreatic Imaging 205
Decoding Grade B Pancreatic Fistula: A Clinical and Economical Analysis and Subclassification Proposal 204
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 204
Delaying surgery for patients with a previous SARS-CoV-2 infection 202
Beyond Pancreatic Cyst Epithelium: Evidence of Ovarian-Like Stroma in EUS-Guided Through-the-Needle Micro-Forceps Biopsy Specimens 201
A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma 199
Gemcitabine-based adjuvant chemotherapy in subtypes of ampullary adenocarcinoma: international propensity score-matched cohort study 196
Local Ablative Strategies for Ductal Pancreatic Cancer (Radiofrequency Ablation, Irreversible Electroporation): A Review 195
Bioethics in an oncological surgery unit during the COVID-19 pandemic: the Verona experience 194
Acinar Cystic Transformation of the Pancreas: Histomorphology and Molecular Analysis to Unravel its Heterogeneous Nature 192
Preoperative surveillance rectal swab is associated with an increased risk of infectious complications in pancreaticoduodenectomy and directs antimicrobial prophylaxis: an antibiotic stewardship strategy? 192
MR imaging and MR cholangiopancreatography of multifocal intraductal papillary mucinous neoplasms of the side branches: MR pattern and its evolution(Article) [Risonanza magnetica (RM) e colangiopancreatografia con RM (CPRM) dei tumori intraduttali papillari mucino-secernenti (TIPM) multifocali dei dotti pancreatici secondari: Semeiotica ed evoluzione] 191
Pancreatic Hepatoid Carcinoma: A Review of the Literature 191
FAM49B, a novel regulator of mitochondrial function and integrity that suppresses tumor metastasis 191
Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment 191
Obstructive chronic pancreatitis and/or intraductal papillary mucinous neoplasms (IPMNs): a 21-year long case report. 190
A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer 190
Role of unlabelled somatostatin analogues in the prevention of complications after elective pancreatic and peripancreatic surgery: a critical review 189
Amylase value in drains after pancreatic resection as predictive factor of postoperative pancreatic fistula - Results of a prospective study in 137 patients 189
Oncocytic Intraductal Papillary Mucinous Neoplasms of the Pancreas: Imaging and Histopathological Findings 189
Anastomotic leakage in pancreatic surgery. 188
Biliary fistula after pancreaticoduodenectomy: data from 1618 consecutive pancreaticoduodenectomies 188
Cost-effectiveness and quality of life analysis of laparoscopic and robotic distal pancreatectomy: a propensity score-matched study 188
Anastomotic leakeage in pancreatic surgery 187
Reconstruction by pancreaticojejunostomy versus pancreaticogastrostomy following pancreatectomy: results of a comparative study. 187
Erratum to: Branch duct IPMTs: value of cross-sectional imaging in the assessment of biological behavior and follow-up 187
Anastomotic leakage in pancreatic surgery. 186
Clinical Implications of the 2016 International Study Group on Pancreatic Surgery Definition and Grading of Postoperative Pancreatic Fistula on 775 Consecutive Pancreatic Resections 186
Dual-tracer (68Ga-DOTATOC and 18F-FDG-)-PET/CT scan and G1-G2 non-functioning pancreatic neuroendocrine tumors: A single-center retrospective evaluation of 124 non-metastatic resected cases 186
11-6: CONTINUOUS GLUCOSE MONITORING AND ASSESSMENT OF LONG-TERM ISLET FUNCTION IN AUTOLOGOUS ISLET TRANSPLANTATION AFTER TOTAL PANCREATECTOMY FOR PANCREATIC NEOPLASIA: PRELIMINARY DATA FROM THE VERONA COHORT 185
Results of a surveillance protocol for pancreatic BD-IPMNs 185
Distal Pancreatectomy Fistula Risk Score (D-FRS): Development and International Validation 184
Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. 184
Enucleation of pancreatic neoplasms. 184
Pancreaticoduodenectomy for distal cholangiocarcinoma: surgical results, prognostic factors, and long-term follow-up 184
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 183
A dynamic analysis of empirical survival outcomes after pancreatectomy for pancreatic ductal adenocarcinoma 183
Risk Adapted Ablative Radiotherapy After Intensive Chemotherapy for Locally Advanced Pancreatic Cancer 183
Clinical and biological behavior of pancreatic solid pseudopapillary tumors: report on 31 consecutive patients. 183
Laparoscopic distal pancreatectomy: analysis of trends in surgical techniques, patient selection, and outcomes 182
Ablation treatments in unresectable pancreatic cancer 182
Results of 100 pancreatic radiofrequency ablations in the context of a multimodal strategy for stage III ductal adenocarcinoma 182
Prophylaxis for septic complications in acute necrotizing pancreatitis 181
Incidence of cancer in the course of chronic pancreatitis 180
An unforeseeable adverse event during ERCP 179
Chyle leak after pancreatic surgery: validation of the International Study Group of Pancreatic Surgery classification 179
Diabetes mellitus does not impact on clinically relevant pancreatic fistula after partial pancreatic resection for ductal adenocarcinoma. 177
Dental plaque microbiota sequence counts for microbial profiling and resistance genes detection 176
Mucinous cystic neoplasms and serous cystadenomas arising in the body-tail of the pancreas: MR imaging characterization 176
CD117 Is a Specific Marker of Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas, Oncocytic Subtype 176
Secretin-enhanced MRCP in the Evaluation of IPMTs of the Collateral Branches 175
Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration 175
Epithelial-mesenchymal transition in undifferentiated carcinoma of the pancreas with and without osteoclast-like giant cells 175
Analysis and proceeding to full publication of abstracts presented at the Pancreas Club annual meeting 175
Actual malignancy risk of either operated or non-operated presumed mucinous cystic neoplasms of the pancreas under surveillance 175
Totale 20.770
Categoria #
all - tutte 233.977
article - articoli 225.347
book - libri 0
conference - conferenze 3.290
curatela - curatele 0
other - altro 356
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.984
Totale 467.954


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021576 0 0 0 0 0 0 0 0 0 89 315 172
2021/20222.926 271 700 58 193 114 105 73 198 146 76 258 734
2022/20237.190 459 779 594 1.193 590 1.700 148 559 815 73 169 111
2023/20244.246 155 362 390 510 456 648 267 278 64 168 703 245
2024/202511.074 583 569 408 1.724 614 353 725 580 1.571 748 1.100 2.099
2025/202634.248 2.305 2.145 2.861 5.698 8.888 2.338 3.147 1.966 2.918 1.982 0 0
Totale 72.131